Yongzhi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yongzhi Wang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alexandros Karagiannopoulos
Exodiab, Lund University Diabetes Centre, Lund University, Malmö, Sweden
1 shared publication - Cheng Luan
Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden
1 shared publication - Enming Zhang
Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, 20213 Malmö, Sweden
1 shared publication - Erik Renström
Section for Islet Pathophysiology, Department of Clinical Sciences Lund University Malmö Sweden
1 shared publication - Haiqiang Dou
Metabolic Research Unit Department of Physiology Sahlgrenska Academy University of Gothenburg Medicinaregatan 11–13 Gothenburg 41390 Sweden
1 shared publication - Lena Eliasson
SciLifeLab, Lund University, Lund, Sweden
1 shared publication
Latest Publications
- Open Access
- 22 July 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
A critical role of the mechanosensor PIEZO1 in glucose-induced insulin secretion in pancreatic β-cells
Glucose-induced insulin secretion depends on β-cell electrical activity. Inhibition of ATP-regulated potassium (KATP) channels is a key event in this process. However, KATP channel closure alone is not sufficient to induce β-cell electrical activity; activation of a depolarizing membrane current is also required. Here we examine the role of the mechanosensor ion channel PIEZO1 in this process. Yoda1, a specific PIEZO1 agonist, activates a small membrane current and thereby triggers β-cell electrical activity with resultant stimulation of Ca2+-influx and insulin secretion. Conversely, the PIEZO1 antagonist GsMTx4 reduces glucose-induced Ca2+-signaling, electrical activity and insulin secretion. Yet, PIEZO1 expression is elevated in islets from human donors with type-2 diabetes (T2D) and a rodent T2D model (db/db mouse), in which insulin secretion is reduced. This paradox is resolved by our finding that PIEZO1 translocates from the plasmalemma into the nucleus (where it cannot influence the membrane potential of the β-cell) under experimental conditions emulating T2D (high glucose culture). β-cell-specific Piezo1-knockout mice show impaired glucose tolerance in vivo and reduced glucose-induced insulin secretion, β-cell electrical activity and Ca2+ elevation in vitro. These results implicate mechanotransduction and activation of PIEZO1, via intracellular accumulation of glucose metabolites, as an important physiological regulator of insulin secretion.
- 22 July 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Open AccessA critical role of the mechanosensor PIEZO1 in glucose-induced insulin secretion in pancreatic β-cells
Glucose-induced insulin secretion depends on β-cell electrical activity. Inhibition of ATP-regulated potassium (KATP) channels is a key event in this process. However, KATP channel closure alone is not sufficient to induce β-cell electrical activity; activation of a depolarizing membrane current is also required. Here we examine the role of the mechanosensor ion channel PIEZO1 in this process. Yoda1, a specific PIEZO1 agonist, activates a small membrane current and thereby triggers β-cell electrical activity with resultant stimulation of Ca2+-influx and insulin secretion. Conversely, the PIEZO1 antagonist GsMTx4 reduces glucose-induced Ca2+-signaling, electrical activity and insulin secretion. Yet, PIEZO1 expression is elevated in islets from human donors with type-2 diabetes (T2D) and a rodent T2D model (db/db mouse), in which insulin secretion is reduced. This paradox is resolved by our finding that PIEZO1 translocates from the plasmalemma into the nucleus (where it cannot influence the membrane potential of the β-cell) under experimental conditions emulating T2D (high glucose culture). β-cell-specific Piezo1-knockout mice show impaired glucose tolerance in vivo and reduced glucose-induced insulin secretion, β-cell electrical activity and Ca2+ elevation in vitro. These results implicate mechanotransduction and activation of PIEZO1, via intracellular accumulation of glucose metabolites, as an important physiological regulator of insulin secretion.